Ezetimibe-Rosuvastatin Evaluation Study

Evaluation of Ezetimibe and Atorvastatin Coadministration Versus Atorvastatin or Rosuvastatin Monotherapy in Japanese Patients With Hypercholesterolemia (Study P06027)(COMPLETED)

NCT00871351 ·Status: COMPLETED ·Phase: PHASE4

Effectiveness and Safety of Ezetimibe Added to Atorvastatin in Patients With High Cholesterol and Coronary Heart Disease (Study P03740)

NCT00202904 ·Status: COMPLETED ·Phase: PHASE4

A Study to Evaluate the Effectiveness of Ezetimibe/Atorvastatin 10 mg/20 mg Combination Tablet Compared to Marketed Ezetimibe 10 mg and Atorvastatin 20 mg Tablets in Participants With High Cholesterol (MK-0653C-185 AM1)

NCT01370590 ·Status: COMPLETED ·Phase: PHASE3

An OS to Evaluate the Safety & Efficacy of Fixed Dose Combination Therapy With Atorvastatin and Ezetimibe

NCT05559606 ·Status: COMPLETED

To Evaluate Ezetimibe Plus Atorvastatin Versus Atorvastatin in Patients With High Cholesterol Not Controlled on Atorvastatin 20 mg (0653-079)(COMPLETED)

NCT00276458 ·Status: COMPLETED ·Phase: PHASE3

Ezetimibe/Simvastatin (10 mg/40 mg) vs. the Doubling of Atorvastatin in High Risk Participants (MK-0653A-134 AM1)(COMPLETED)

NCT00782184 ·Status: COMPLETED ·Phase: PHASE3

A Prospective, Open Label Comparison of Ezetimibe, Niacin, and Colestipol as Adjunct Therapy in Lipid Reduction

NCT00203476 ·Status: COMPLETED ·Phase: PHASE4

A Study to Assess the Cholesterol Lowering Effect of Ezetimibe/Simvastatin Combination Tablet Compared to Another Cholesterol Lowering Drug in Elderly Patients With High Cholesterol at High or Moderately High Risk for Coronary Heart Disease (0653A-128)

NCT00535405 ·Status: COMPLETED ·Phase: PHASE3

Ezetimibe Plus Atorvastatin Versus Atorvastatin in Untreated Subjects With High Cholesterol (P03434)

NCT00653796 ·Status: COMPLETED ·Phase: PHASE4

Comparison of Simvastatin Versus Simvastatin/Ezetimibe on Small Dense Low -Density Lipoprotein (LDL)

NCT00932620 ·Status: COMPLETED ·Phase: PHASE4

A Long-term Safety and Tolerability Study of Ezetimibe Plus Atorvastatin in Participants With Coronary Heart Disease, Multiple Risk Factors, or Hypercholesterolemia Not Controlled by Atorvastatin (P01418/MK-0653-032)

NCT03882996 ·Status: COMPLETED ·Phase: PHASE3

Comparison of Ezetimibe Added to Ongoing Statin Therapy Versus Doubling the Dose of Statin in the Treatment of Hypercholesterolemia (P04355)

NCT00652327 ·Status: COMPLETED ·Phase: PHASE4

Randomized Parallel Group Trial Of The Efficacy And Safety Of Ezetimibe With A Statin Versus Statin Dose Doubling In Patients With Persistent Primary Hypercholesterolemia (0653-152)(COMPLETED)

NCT00652847 ·Status: COMPLETED ·Phase: PHASE4

Ezetimibe (SCH 58235) Taken With Either Atorvastatin or Simvastatin in Participants With Familial Hypercholesterolemia (MK-0653-018)

NCT03884452 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate the Effect of Obicetrapib in Combination With Ezetimibe as an Adjunct to HIS Therapy

NCT05266586 ·Status: COMPLETED ·Phase: PHASE2

Study of an Approved Drug With a Statin (a Medication That Lowers Cholesterol Levels) as Compared to Statin Therapy Alone in Patients With High Cholesterol (0653-040)

NCT00092586 ·Status: COMPLETED ·Phase: PHASE3

A Study of LY3015014 in Participants With High Cholesterol

NCT01890967 ·Status: COMPLETED ·Phase: PHASE2

Phase IV Study to Evaluate the Effects of Statin Monotherapy or Statin / Ezetimibe Combination Therapy on Hepatic Steatosis in Patients With Hyperlipidemia and Nonalcoholic Fatty Liver Disease

NCT03434613 ·Status: COMPLETED ·Phase: PHASE4

Comparing an Investigational Medication Versus an Approved Medication in Reducing Cholesterol Levels (0653-025)

NCT00092716 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) 180mg, Ezetimibe 10mg, and Atorvastatin 20 mg Triplet Therapy in Patients With Elevated LDL-C

NCT03051100 ·Status: COMPLETED ·Phase: PHASE2

A Study Comparing Ezetimibe Plus Simvastatin Versus Simvastatin Alone in Patients at Risk for Heart Disease (0653-023)(COMPLETED)

NCT00551447 ·Status: COMPLETED ·Phase: PHASE3

Ezetimibe Plus Atorvastatin Versus Atorvastatin in Untreated Subjects With Primary Hypercholesterolemia and Coronary Heart Disease (P03396)

NCT00650689 ·Status: COMPLETED ·Phase: PHASE3

Long-Term Safety and Tolerability of Ezetimibe (SCH 58235, MK-0653) With Atovastatin (P02154, MK-0653-017)

NCT03882892 ·Status: COMPLETED ·Phase: PHASE3

An Efficacy and Safety Study of Ezetimibe (MK-0653, SCH 58235) in Addition to Atorvastatin Compared to Placebo in Participants With Primary Hypercholesterolemia (MK-0653-013)

NCT03867110 ·Status: COMPLETED ·Phase: PHASE3

Ezetimibe In Addition To Atorvastatin Therapy On The Plaque Composition In Patients With Acute Myocardial Infarction.

NCT01385631 ·Status: COMPLETED ·Phase: PHASE4